RBC cuts Chewy stock price target on weaker category outlook

RBC Capital cut Chewy’s price target to $34 from $47 while keeping an Outperform rating, citing a more challenging category outlook and slower growth assumptions. The firm now expects Q2 net sales growth of 6.8% versus 8.4% previously, with fiscal 2026/2027 sales growth trimmed to 6.9% and 7.4% and EBITDA forecasts lowered to $889 million and $1.05 billion. Chewy’s stock trades at $19.20, near its 52-week low of $19.08, as analysts broadly turn more cautious despite a modest Q1 revenue and EBITDA beat.

Analysis

CHWY is less a one-quarter miss story than a re-rating of the category itself: when growth is already decelerating, every point of top-line slowdown has an outsized impact on valuation because fixed fulfillment, marketing, and tech costs do not flex down cleanly. That makes the stock vulnerable to multiple compression even if near-term EBITDA holds, since investors are underwriting a path from a mature but still subscale platform to sustained share gains that now looks slower and more expensive to prove.

The second-order effect is pressure on the broader e-commerce pet ecosystem: weaker category demand usually shifts spend toward essentials, private label, and promoted SKUs, which can crowd out premium discretionary baskets and reduce monetization per order. That dynamic is bearish for higher-beta consumer internet names that depend on repeated customer acquisition rather than pricing power, and it can also ripple back to suppliers if promotions become the only lever to sustain traffic.

The consensus may be over-penalizing the near-term while still underestimating the duration of the reset. If management has already telegraphed the guide cut, the immediate downside may be more about estimate drift than a new negative surprise; however, the real risk is that slower category growth persists for several quarters, forcing another round of multiple compression before any operating leverage thesis can work. In that setup, the stock can bounce on quarterly beats but still remain trapped until comps stabilize and the market sees evidence of durable share gains rather than just margin management.

Contrarianly, the bear case is crowded enough that a modestly better-than-feared print or cleaner commentary on retention and frequency could spark a sharp relief rally. The asymmetry is to the upside in the very near term if short interest is leaning on weak sentiment, but the medium-term risk/reward still favors fading strength unless we see a meaningful inflection in category demand or advertising efficiency.

Key Decisions for Investors

• Maintain a tactical short/underweight in CHWY into the next earnings window; use strength toward the low-$20s to add, with a 1-2 quarter horizon and downside toward the high-teens if category deceleration persists.
• For a cleaner risk-defined expression, buy CHWY put spreads 2-4 months out; target a 2:1 payoff if the market starts discounting another guide reset or multiple compression below ~12x forward EBITDA.
• Pair trade: long defensives with pricing power (e.g., COST or WMT) vs short CHWY for 1-3 months, betting that consumers trade down to essentials and away from discretionary pet basket expansion.
• If already short, cover into any relief rally on a beat-and-raise-lite quarter; the near-term squeeze risk is elevated because expectations are now low enough that even slight operational stability can trigger multiple re-rating.
• Avoid chasing the long side until there is evidence of category stabilization over at least two reporting periods; without that, upside is likely capped by continued estimate cuts.